Evidence map›Paper›PMID 40901439›Full record

ArticleJournal of advanced pharmaceutical technology & research

Development of a BALB/c mice model for blue light retinal damage.

Arief Wildan, Banundari Rachmawati, Arief Sjamsulaksan Kartasasmita, Fifin Luthfia Rahmi, Maharani, Hermawan Istiadi, Anditta Syifarahmah, Irwan Nurdiansyah, Noviana Fitri Wulandari, Shofia Salsabilah

Abstract read
In one paragraph

Article in Journal of advanced pharmaceutical technology & research. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Arief WildanDoctoral Study Program of Medical and Health Science, Semarang, Central Java, Indonesia.
Banundari RachmawatiDepartment of Clinical Pathology, Faculty of Medicine, Semarang, Central Java, Indonesia.
Arief Sjamsulaksan KartasasmitaVitreoretina Division, Department of Ophthalmology, Faculty of Medicine, Padjadjaran University, Bandung, West Java, Indonesia.
Fifin Luthfia RahmiVitreoretina Division, Department of Ophthalmology, Faculty of Medicine, Semarang, Central Java, Indonesia.
MaharaniVitreoretina Division, Department of Ophthalmology, Faculty of Medicine, Semarang, Central Java, Indonesia.
Hermawan IstiadiGlaucoma Division, Department of Ophthalmology, Faculty of Medicine, Semarang, Central Java, Indonesia.
Anditta SyifarahmahVitreoretina Division, Department of Ophthalmology, Faculty of Medicine, Semarang, Central Java, Indonesia.
Irwan NurdiansyahVitreoretina Division, Department of Ophthalmology, Faculty of Medicine, Semarang, Central Java, Indonesia.
Noviana Fitri WulandariDepartment of Anatomy Pathology, Faculty of Medicine, Diponegoro University, Semarang, Central Java, Indonesia.
Shofia SalsabilahFaculty of Medicine, Diponegoro University, Semarang, Central Java, Indonesia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Blue light exposure can damage the retina, resulting in retinal atrophy and significant vision loss. Currently, no efficient animal models can observe retinal damage caused by blue light within a defined timeframe. Creating a BALB/c mouse model for blue light-induced retinal damage is expected to enhance research focused on the prevention and treatment of age-related macular degeneration. This study explores the potential effect of blue light exposure on the BALB/c mice model by analysing apoptosis and retinal degeneration. Anatomical Pathology Laboratory of Diponegoro University and The Integrated Research and Testing Laboratory of Gadjah Mada University. This study design was a posttest-only control group design. Ten five-week-old BALB/c mice were divided into two groups. The exposure group received 10,000 lux of blue light in the special cage for 2 weeks, 3 h daily. Caspase-3 expression was assessed through polymerase chain reaction testing, and retinal thickness was analyzed using hematoxylin and eosin staining. We used the Shapiro-Wilk test to evaluate data normality. Parametric

Indexed as

Age-related macular degenerationBALB/c miceblue light-inducedretinal thickness

Identifiers

PMID40901439
PMCPMC12401520

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.